ABSTRACT This paper summarizes the panel discussion at the IEEE Engineering in Medicine and Biology Point-of-Care Healthcare Technology Conference (POCHT 2013) held in Bangalore India from Jan 16-18, 2013. Modern medicine has witnessed interdisciplinary technology innovations in healthcare with a continuous growth in life expectancy across the globe. However, there is also a growing global concern on the affordability of rapidly rising healthcare costs. To provide quality healthcare at reasonable costs, there has to be a convergence of preventive, personalized, and precision medicine with the help of technology innovations across the entire spectrum of point-of-care (POC) to critical care at hospitals. The first IEEE EMBS Special Topic POCHT conference held in Bangalore, India provided an international forum with clinicians, healthcare providers, industry experts, innovators, researchers, and students to define clinical needs and technology solutions toward commercialization and translation to clinical applications across different environments and infrastructures. This paper presents a summary of discussions that took place during the keynote presentations, panel discussions, and breakout sessions on needs, challenges, and technology innovations in POC technologies toward improving global healthcare. Also presented is an overview of challenges and trends in developing and developed economies with respect to priority clinical needs, technology innovations in medical devices, translational engineering, information and communication technologies, infrastructure support, and patient and clinician acceptance of POC healthcare technologies.
I. INTRODUCTION
The twentieth century witnessed a technology revolution in medicine and health through instrumentation, computer and information and communication technologies. This revolution has continued in the twenty-first century, with smart cross-and trans-disciplinary technologies and innovations directly impacting medical practice and healthcare delivery, which, in turn, have redefined the relationship between patients and healthcare providers. Technology innovations and globalization have brought the world together as one global community where developing and developed economies have become more dependent and well connected than in previous times. As the overall life expectancy across the globe has increased, the global community is now facing new challenges of improving quality of life and healthcare at an affordable cost. While the exponentially rising cost of healthcare, defined as total healthcare expenditure as a percentage of a nation's Gross Domestic Product (GDP), is a critical priority challenge in developed nations, providing minimal quality healthcare to all, specifically large and sparsely distributed communities living in rural areas, is the most vital challenge to developing nations.
A necessary component of affordable global healthcare is Point-of-Care (POC) healthcare technologies, and developing POC technologies will require continuous evolution of innovation in smart and portable bio-sensor, computing, information and communication technologies. A strategic study at the National Institutes of Health has noted (http:// report.nih.gov/NIHfactsheets/ViewFactSheet. aspx?csid=112) [1] : ''With the development of miniaturized devices and wireless communication, the way in which doctors care for patients will change dramatically and the role patients take in their own healthcare will increase. Healthcare will become more personalized through tailoring of interventions to individual patients. '' Though the challenges of providing high-quality healthcare in developing countries are different than those in developed countries, they share a common goal: to provide access to health monitoring and assessment technologies to people with limited or no healthcare facilities, or with geographically distant or difficult to physically access facilities. While developed countries may find POC technologies an effective means for reducing healthcare costs and improving efficiency, POC technologies are critical in the provision of diagnostic and monitoring healthcare needs in countries with large populations or rural areas. The developing countries in the eastern part of the globe, which account for more than two-thirds of the population of the world, face the basic challenge of providing minimal healthcare to all people living in adverse geographical or economic constraints, and also monitoring critical infectious diseases such as HIV/AIDS, TB, malaria, etc. The challenge becomes even more critical in potential epidemic situations.
Given the rapidly aging populations in both developed and developing nations, it is now more critical than ever to develop collaborative synergies to explore POC health monitoring, assessment and therapeutic technologies to significantly impact global healthcare for the ''well-being'' of a healthy society.
However, the implementation of POC healthcare technologies towards a tangible clinical impact poses formidable challenges in educating users. Not only must users and local support staff learn about technology usage, measurement techniques, data communication and compliance, patients and family members must undergo a behavioral change to understand and accept new roles and responsibilities in keeping themselves, family members, and others healthy. The concept of self-care must be a major flagship in this education process. POC healthcare technologies (including sensor-and biomarkers-based POC diagnostic technologies; therapeutic and rehabilitation devices; and information and communication technology (ICT) with mHealth, eHealth, and health monitoring with POC decision support systems) will directly impact patients, support staff, community center workers, and nurses, among others. All of these users will have to become comfortable, to varying degrees, with technology usage and local decision-making. In addition, physicians and business managers will also need to become conversant in the broad spectrum of data integration, mining and interpretation [2] - [12] .
II. PROCEDURES AND METHODS
The EMBS conference on Point-of-Care Healthcare Technologies invited scientific researchers and innovators, industry leaders, clinical experts, and policy makers from the USA, Hong Kong, China, Japan, Europe and India as plenary, keynote and panel speakers. This white paper was developed out of those presentations, as well as panel discussions, data presented, and comments made during breakout sessions, using the following multi-step methodology. The conference's first day featured plenary and keynote talks by leaders and representatives from government agencies including Roderic Pettigrew, MD, PhD, Institute Director, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health (USA); senior leaders from global industries including IBM Life Sciences and Medtronic (USA and India); experts from clinical healthcare facilities including the Cardiology Department, Kyushu University Hospital (Japan) and Apollo Hospital (India); and biomedical researchers and innovators. These talks were followed by a panel discussion led by representatives from stakeholder groups from all over the globe. Both the plenary and keynote talks and the expert panel discussed current and future challenges in global healthcare. After these interactive panel discussions with over 176 researchers and stakeholders, the following steps were implemented to systematically collect insights from the various discussions generated by the conference program, including two additional panel discussions and three breakout sessions. Conference attendees represented a rich spectrum of clinical practitioners, industry experts and entrepreneurs, academic researchers, and policy makers (Table 1) . This paper represents the summary of discussions, data and comments made during the conference events.
1. A questionnaire was circulated after the first panel discussion to all attendees requesting them to identify Future Trends and Follow-up. The discussions were summarized further in the raw data. 4. The speakers from Panel Discussion 2 session formed a committee of authors and prepared a report that was transformed into the content of this paper. The paper went through three iterations to help ensure that it was an accurate record of the conference and that all points of view were included.
III. POINT-OF-CARE HEALTHCARE TECHNOLOGIES (POCHT): A PARADIGM SHIFT IN AFFORDABLE QUALITY GLOBAL HEALTHCARE
POCHT is a paradigm-shift in global healthcare. However, such technologies do not exist in isolation and must be integrated into and adopted by new or existing health service delivery models, be supported by sound business cases, and show demonstrated levels of improvement to patient health outcomes in terms of such metrics as qualityadjusted life years (QALYs) as a means of quantifying disease burden. Development, deployment and compliance issues related to affordable global healthcare have to be critically examined towards the creation of sound business models for their effective implementation such that they can be sustained with an economic impact.
What is striking about the concept of POCHT is its near universality of potential application. There is benefit to the management and treatment of most diseases -hence priorities mirror the prevalence of disease in each country. There is applicability to both wealthy and developing countries with cross-fertilization of design back and forth among all nations, with both simple and advanced technologies being of use to all [2] - [8] . imagine poor, rural areas where the introduction of paramedical personnel bringing more information coupled with simple monitoring measures of health (blood pressure, heart rate, blood physiology) would have significant impact on people's behavior and lives. At the other extreme, POCHT technologies are already in the hands of wealthy, educated people in the form of smartphone applications for monitoring exercisethere will be a continuing and rapid growth of monitoring capability for this population that already wants to change its behavior. Aggressive development -either private, profit-making or government -could bring these behavior-changing technologies to ever-wider populations [8] , [12] . (e) Medical information: The ability to collect medical and healthcare information locally and aggregate centrally has strong implications for epidemiology and for planning the availability of medical supplies and resources (supply-chain management). A form of this already exists in the RFID of equipment for inventory within hospitals.
V. POC HEALTHCARE TECHNOLOGIES
There is strong consensus that several technologies are already having a huge impact on society at large, with impacts on healthcare to follow. (a) Low cost sensor technologies: There are several prototypical examples.
(i) Perhaps ubiquitous is the smartphone capable of a number of diagnostic measurements, including EKG / heart rate, breathing rate, blood pressure, blood oxygen saturation, image recognition for skin disease (ii) Low cost blood chemistry sensors, ranging from the more straightforward (blood glucose) to the highly sophisticated (detectors for dengue fever, on chip PCR) (iii) Reduced-cost versions of historically expensive technologies -an example is ultrasound machines whose cost now permits wide distribution (b) Communications and computational technology:
Smartphones put more computer power in the hands of a common person than a computer engineer dreamed of 50 years ago. Wireless and satellite communications have revolutionized the communications world. The development of these technologies is practically ''for free'' as other markets are driving the cost and availability faster than the medical applications would. The goal is to harness these technologies, not develop them. (c) Modeling and simulation from physiology to behavior:
As more point-of-care data become available, there will be increasing need for models of increasing complexity to assist in analysis. An example is modeling the daily activity patterns of the elderly to predict medical problems. More generally, the ability to use data to anticipate individual problems is a key component of personalized medicine. (d) Automated decision-making and support: We have now seen more than a decade of on-line medical diagnostic information services, which will continue to grow in sophistication. There is tremendous potential for exploiting the spectacular medical research knowledge base, advancing the practice of evidence-based medicine on a world wide scale. The initial cost is very high, but the delivery cost is very low given the communications technology. This technology can scale for the use of the expert, the general practitioner, the nurse, and the paramedical professional. (e) Accessible data structures: The delivery of the benefits of POCTH will be greatly assisted by enhanced accessibility of data to the broader medical community. There are a variety of competing issues to achieving this goal, including security and privacy of data, interoperability of data structures, and ownership of data. patient information; and access to expert information and to one's own records.
VI. STRATEGIC ENABLERS

VII. POCHT CLINICAL IMPACT
Clinical impact can be realized in preventive, therapeutic and surveillance areas. In the preventive area, POCHT impact may be appreciable only after a few years. For example, a decline in the incidence of myocardial infarction after good control of diabetes, cholesterol and blood pressure will take years to realize. The impact in the therapeutic area can be more readily assessed after POCT implementation. For example, the Apollo Hospital in India uses cardio biomarkers in early diagnosis of myocardial infarction and early transfer to the ICU. It can be readily shown that POCT has a favorable impact on the hospital's cardiac mortality. Similarly, use of antenatal POCHT kits in diagnosing early eclampsia or anemia can be easily shown to reduce maternal mortality rate. Surveillance POCHT is similar to preventive POCHT where the actual clinical impact may be appreciable only after a few years. The major challenge would be in data acquisition, communication, and patient compliance, specifically in developing economies. The major challenge is in task shifting: shift of preliminary or pre-diagnosis responsibility at the point-of-care. Other challenges include developing pathways to provide [8] - [12] : (a) Evidence-based personalized care; (b) Patient centered precision medicine; (c) Preventive healthcare; (d) Short-term feedback with long-term benefits; (e) Cost-effectiveness, specifically in mass screening (e.g., diabetes and hypertension monitoring); (f) Easy and intuitive devices and decision support systems. The medical devices and informational communication technologies at the point-of-care also face other societal challenges for acceptance and implementation. These issues include diverse demographic and cultural backgrounds, and differences in needs due to geographical, social, and economic factors. While it makes sense to be patient-centric, empowering ptaients with point-of-care decision support systems raises concerns about legal liability and potential reduction in sensitivity. It is not yet clear how POCT can be used to integrate family members and physicians into one effective healthcare team.
VIII. CONCLUDING REMARKS AND RECOMMENDATIONS
Though the challenges of providing high-quality healthcare in developing countries are different than those in developed countries, there is a common goal to provide access to health monitoring and assessment technologies to people with limited or no healthcare facilities. Large developing nations with fast economic growth such as India and China are committed to providing healthcare to all, but they still face major challenges in assessing rural and underserved patients' healthcare needs and in providing them with timely quality healthcare at the point-of-care. This is also a critical challenge in metropolitan areas where the hospital and primary healthcare facilities are overburdened. Major challenging priority areas where healthcare is most needed for people in India, as identified by WHO, are: hypertension and cardiac deaths, diabetes, cancers, women's health (specifically child birth) and infant mortality, and neurological disorders [13] . Use of advanced point-of-care technologies, including wearable sensors, biomarkers, and mobile-communications-based education, along with health data collection and analysis, is a viable and affordable way to reach larger populations for better healthcare and compliance. The impact on quality of life from better outreach, increased affordability of quality primary care, and increased patient compliance would be tremendously positive.
It is important to consider perspectives from all stakeholders, including patients, industry, healthcare providers, payers, policy makers and society as a whole (Fig. 1) . In order for the POCHT paradigm shift to lead to transformational change, POCHT technologies must address critical issues in patient privacy, data integrity and security on one hand, but also infrastructure support and policies on the other hand. These infrastructure and policy supports will need to enable data and decision-support systems for all stakeholder groups in healthcare: patients at point-of-care, clinicians at healthcare facilities, and payers at the insurance or provider levels.
All of these stakeholder groups must be willing to accept the challenges and potential errors that might impact the sensitivity and specificity of healthcare processes. In addition, clinicians and community members, such as community health workers, will need to help patients accept responsibility and accountability for their own health as they are empowered to address their health issues, illnesses, and preventive care in order to remain healthy. Thus patients, families, and communities will need to learn to think in new ways about the use of technology and how to responsibly monitor their health when applying POC healthcare technologies and decision-support systems.
The transformational change in defining new roles and responsibilities for patients has to come through VOLUME 3, 2015 patient-centered design, local solutions, and sensitive patient-education on POC benefits, such as significant costsavings, reduced hospitalizations, and better personalized and preventive healthcare. The outreach to patients for POC education and monitoring may incorporate specific innovative methods such as smartphone ICT and incentives from healthcare providers, payers and government. For example, many developing and developed countries are encouraging continuous monitoring of blood glucose and hypertension through innovative programs including educational camps and free or heavily discounted prices of monitoring systems. Of course, the economic aspects of such initiatives in developing countries can cause critical challenges in implementation involving social and political issues. Recent studies on the economic impact of using POC technologies in economically challenged nations presented in references [12] - [15] summarize that these socio-economic and infrastructure challenges may at first overshadow the benefits of POC technologies. Yet, in the long run, POC technologies with smart ICT hold tremendous hope for sustainably managing resources and improving healthcare delivery in rural and developing nations.
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